Minerva Neurosciences to host expert event on roluperidone for negative symptoms of schizophrenia

NERV•2026-10-28

Minerva Neurosciences will host an in-person and virtual event in New York on Nov. 12, 2026, to discuss roluperidone analyses and provide an update on its ongoing Phase 3 trial.

Minerva Neurosciences to host expert event on roluperidone for negative symptoms of schizophrenia

1. Event details

Related News

Hope Bancorp expects 2026 revenue growth of about 16%-18%

Lincoln Educational Services Corp: B. Riley cuts target price to $52.00 from $56.00

Kratos wins $33.6 million contract for NASA spacecraft power system

Bombardier, UK's BAE explore partnership for future combat aircraft programs

Franklin Electric Q3 sales top expectations on Cat Pumps acquisition